The acute respiratory distress syndrome (ARDS) has multiple causes and is characterized by acute lung inflammation and increased pulmonary vascular permeability, leading to hypoxemic respiratory failure and bilateral pulmonary radiographic opacities. The acute respiratory distress syndrome is associated with substantial morbidity and mortality, and effective treatment strategies are limited. This review presents the current state of the literature regarding the etiology, pathogenesis, and management strategies for ARDS.
AshbaughDBigelowDBPettyTLevineB. Acute respiratory distress in adults. Lancet. 1967;290(7511):319–323.
2.
LuhrORAntonsenKKarlssonM, et al.Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med. 1999;159(6):1849–1861.
3.
VillarJ. What is the acute respiratory distress syndrome?Respir Care. 2011;56(10):1539–1545.
4.
BerstenADEdibamCHuntT, et al.Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am J Respir Crit Care Med. 2002;165(4):443–448.
5.
StapletonRDWangBMHudsonLDRubenfeldGDCaldwellESSteinbergKP. Causes and timing of death in patients with ARDS. Chest. 2005;128(2):525–532.
6.
EricksonSEMartinGSDavisJLMatthayMAEisnerMDNetworkNNA. Recent trends in acute lung injury mortality: 1996–-2005. Crit Care Med. 2009;37(5):1574–1579.
7.
RubenfeldGDCaldwellEPeabodyE, et al.Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685–1693.
8.
BellaniGLaffeyJGPhamT, et al.Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788–800.
9.
BernardGRArtigasABrighamKL, et al.The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 pt 1):818–824.
10.
RanieriVMRubenfeldGDThompsonBTet al; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533.
11.
FergusonNDFanECamporotaL, et al.The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573–1582.
12.
KatzensteinALBloorCMLeibowAA. Diffuse alveolar damage – the role of oxygen, shock, and related factors. A review. Am J Pathol. 1976;85(1):209–228.
13.
PiantadosiCASchwartzDA. The acute respiratory distress syndrome. Ann Intern Med. 2004;141(6):460–470.
14.
AndersonWRThielenK. Correlative study of adult respiratory distress syndrome by light, scanning, and transmission electron microscopy. Ultrastruct Pathol. 1992;16(6):615–628.
15.
PrattPCVollmerRTShelburneJDCrapoJD. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. Am J Pathol. 1979;95(1):191–214.
16.
BachofenMWeibelER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis. 1977;116(4):589–615.
17.
PierrakosCKaranikolasMScollettaSKaramouzosVVelissarisD. Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res. 2012;4(1):7–16.
18.
de HemptinneQRemmelinkMBrimioulleSSalmonIVincentJL. ARDS: a clinicopathological confrontation. Chest. 2009;135(4):944–949.
19.
SarmientoXGuardiolaJJAlmirallJ, et al.Discrepancy between clinical criteria for diagnosing acute respiratory distress syndrome secondary to community acquired pneumonia with autopsy findings of diffuse alveolar damage. Respir Med. 2011;105(8):1170–1175.
20.
EstebanAFernández-SegovianoPFrutos-VivarF, et al.Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med. 2004;141(6):440–445.
21.
PinheiroBVMuraokaFSAssisRVC, et al.Accuracy of clinical diagnosis of acute respiratory distress syndrome in comparison with autopsy findings. J Bras Pneumol. 2007;33(4):423–428.
22.
KaoKCHuHCChangCH, et al.Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsy. Crit Care. 2015;19(1):228.
23.
ThompsonBTMichaelAM. The Berlin definition of ARDS versus pathological evidence of diffuse alveolar damage. Am J Respir crit Care Med. 2013;187(7):675–677.
24.
HudsonLDMilbergJAAnardiDMaunderRJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir crit Care Med. 1995;151(2 pt 1):293–301.
25.
PepePEPotkinRTReusDHHudsonLDCarricoCJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144(1):124–130.
26.
EworukeEMajorJMGilbert McClainLI. National incidence rates for acute respiratory distress syndrome (ARDS) and ARDS cause-specific factors in the United States (2006-2014). J Crit Care. 2018;47:192–197.
27.
MarshallRPWebbSHillMRHumphriesSELaurentGJ. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest. 2002;121(3 suppl):68S–69S.
28.
MarshallRPWebbSBellinganGJ, et al.Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir crit Care Med. 2002;166(5):646–650.
29.
CoplandIBKavanaghBPEngelbertsDMcKerlieCBelikJPostM. Early changes in lung gene expression due to high tidal volume. Am J Respir crit Care Med. 2003;168(9):1051–1059.
30.
GrigoryevDNFiniganJHHassounPGarciaJGN. Science review: searching for gene candidates in acute lung injury. Crit Care. 2004;8(6):440.
31.
MikkelsenMEShahCVMeyerNJ, et al.The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock. 2013;40(5):375–381.
32.
GajicODabbaghOParkPK, et al.Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir crit Care Med. 2011;183(4):462–470.
33.
FergusonNDFrutos-VivarFEstebanA, et al.Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study. Crit Care. 2007;11(5):R96.
34.
FeinAMCalalang-ColucciMG. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin. 2000;16(2):289–317.
35.
PelosiPD’OnofrioDChiumelloD, et al.Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl. 2003;42:48s–56s.
36.
SheuCCGongMNZhaiR, et al.The influence of infection sites on development and mortality of ARDS. Intensive Care Med. 2010;36(6):963–970.
37.
KojicicMLiGHansonAC, et al.Risk factors for the development of acute lung injury in patients with infectious pneumonia. Crit Care. 2012;16(2):R46.
38.
LeeAFesticEParkPK, et al.Characteristics and outcomes of patients hospitalized following pulmonary aspiration. Chest. 2014;146(4):899–907.
39.
TreggiariMMHudsonLDMartinDPWeissNSCaldwellERubenfeldG. Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med. 2004;32(2):327–331.
40.
CalfeeCSEisnerMDWareLB, et al.Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med. 2007;35(10):2243–2250.
41.
MossMGillespieMKAckersonLMooreFAMooreEEParsonsPE. Endothelial cell activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med. 1996;24(11):1782–1786.
42.
ToyPPopovskyMAAbrahamE, et al.Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005;33(4):721–726.
43.
ZilberbergMDCarterCLefebvreP, et al.Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care. 2007;11(3):R63.
44.
KhanHBelsherJYilmazM, et al.Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007;131(5):1308–1314.
45.
LevittJECalfeeCSGoldsteinBAVojnikRMatthayMA. Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*. Crit Care Med. 2013;41(8):1929–1937.
46.
CraderKMRepineDJJRepineJE. Breath biomarkers and the acute respiratory distress syndrome. J Pulm Respir Med. 2012;2(1):1–9.
47.
DonnellySCStrieterRMKunkelSL, et al.Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 1993;341(8846):643–647.
48.
VillarJPérez-MéndezLEspinosaE, et al.Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One. 2009;4(8):e6818.
49.
AgrawalAMatthayMAKangelarisKN, et al.Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med. 2013;187(7):736–742.
50.
TerpstraMLAmanJvan Nieuw AmerongenGPGroeneveldABJ. Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis*. Crit Care Med. 2014;42(3):691–700.
51.
CalfeeCSWareLBGliddenDV, et al.Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med. 2011;39(4):711–717.
52.
WareLBKoyamaTBillheimerDD, et al.Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest. 2010;137(2):288–296.
53.
IscimenRCartin-CebaRYilmazM, et al.Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med. 2008;36(5):1518–1522.
54.
JiaXMalhotraASaeedMMarkRGTalmorD. Risk factors for ARDS in patients receiving mechanical ventilation for greater than 48 hours. Chest. 2008;133(4):853–861.
55.
YaoSMaoTFangWXuMChenW. Incidence and risk factors for acute lung injury after open thoracotomy for thoracic diseases. J Thorac Dis. 2013;5(4):455–460.
56.
EvansRGNaiduB. Does a conservative fluid management strategy in the perioperative management of lung resection patients reduce the risk of acute lung injury?Interact Cardiovasc Thorac Surg. 2012;15(3):498–504.
57.
HughesCGWeavindLBanerjeeAMercaldoNDSchildcroutJSPandharipandePP. Intraoperative risk factors for acute respiratory distress syndrome in critically ill patients. Anesth Analg. 2010;111(2):464–467.
58.
WiedemannHPWheelerAPBernardGR, et al.Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–2575.
59.
RosenbergALDechertREParkPKBartlettRHNetworkNNA. Review of a large clinical series: association of cumulative fluid balance on outcome in acute lung injury: a retrospective review of the ARDSnet tidal volume study cohort. J Intensive Care Med. 2009;24(1):35–46.
60.
SeeleyEJ. Fluid therapy during acute respiratory distress syndrome: less is more, simplified*. Crit Care Med. 2015;43(2):477–478.
61.
GongMNThompsonBTWilliamsPPothierLBoycePDChristianiDC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005;33(6):1191–1198.
62.
HébertPCWellsGBlajchmanMA, et al.A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, canadian critical care trials group. N Engl J Med. 1999;340(6):409–417.
63.
ParkPKCannonJWYeW, et al.Transfusion strategies and development of acute respiratory distress syndrome in combat casualty care. J Trauma Acute Care Surg. 2013;75(2 suppl 2):S238–S246.
64.
PopovskyMAMooreSB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25(6):573–577.
65.
CurtisBRMcFarlandJG. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies. Critical care medicine. 2006;34(5 suppl):S118–S123.
66.
VlaarAPJuffermansNP. Transfusion-related acute lung injury: a clinical review. Lancet. 2013;382(9896):984–994.
67.
ToyPGajicOBacchettiP, et al.Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119(7):1757–1767.
68.
GajicORanaRWintersJL, et al.Transfusion-related acute lung injury in the critically ill: prospective nested case–control study. Am J Respir Crit Care Med. 2007;176(9):886–891.
69.
PriceTH. Standards for Blood Banks and Transfusion Services. Bethesda, MD: AABB; 2008.
70.
EderAFHerronRStruppA, et al.Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007;47(4):599–607.
71.
SillimanCCThurmanGWAmbrusoDR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. Vox Sanguinis. 1992;63(2):133–136.
72.
TungJPFraserJFNataatmadjaM, et al.Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI). Crit Care. 2012;16(1):R19.
73.
VlaarAPJBinnekadeJMPrinsD, et al.Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case–control study. Crit Care Med. 2010;38(3):771–778.
74.
MiddelburgRABorkent-RavenBABorkentB, et al.Storage time of blood products and transfusion-related acute lung injury. Transfusion. 2012;52(3):658–667.
75.
KorDJKashyapRWeiskopfRB, et al.Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial. Am J Respir Crit Care Med. 2012;185(8):842–850.
76.
FanEBrodieDSlutskyAS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018;319(7):698–710.
77.
HowellMDDavisAM. Management of ARDS in adults. JAMA. 2018;319(7):711–712.
78.
FanEDel SorboLGoligherEC, et al.An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195(9):1253–1263.
79.
FergusonNDCookDJGuyattGH, et al.High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med. 2013;368(9):795–805.
80.
LallRHamiltonPYoungD, et al.A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) study. Health Technol Assess. 2015;19(23):1–177, vii.
81.
SudSSudMFriedrichJO, et al.High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome. Cochrane Database Syst Rev. 2016;(4):CD004085.
82.
CombesAHajageDCapellierG, et al.Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965–1975.
83.
CavalcantiABSuzumuraEALaranjeiraLN, et al.Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2017;318(14):1335–1345.
84.
AmatoMBMeadeMOSlutskyAS, et al.Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372(8):747–755.
85.
GrassoSFanelliVCafarelliA, et al.Effects of high versus low positive end-expiratory pressures in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2005;171(9):1002–1008.
86.
VieiraSRPuybassetLLuQ, et al.A scanographic assessment of pulmonary morphology in acute lung injury. Significance of the lower inflection point detected on the lung pressure-volume curve. Am J Respir Crit Care Med. 1999;159(5 pt 1):1612–1623.
87.
GattinoniLCaironiPCressoniM, et al.Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med. 2006;354(17):1775–1786.
88.
PutensenCMutzNJPutensen-HimmerGZinserlingJ. Spontaneous breathing during ventilatory support improves ventilation-perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;159(4 pt 1):1241–1248.
89.
PutensenCZechSWriggeH, et al.Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med. 2001;164(1):43–49.
90.
RoySHabashiNSadowitzB, et al.Early airway pressure release ventilation prevents ARDS – a novel preventive approach to lung injury. Shock. 2013;39(1):28.
91.
EmrBGattoLARoyS, et al.Airway pressure release ventilation prevents ventilator-induced lung injury in normal lungs. JAMA Surg. 2013;148(11):1005–1012.
92.
AndrewsPLShiberJRJaruga-KilleenE, et al.Early application of airway pressure release ventilation may reduce mortality in high-risk trauma patients: a systematic review of observational trauma ARDS literature. J Trauma Acute Care Surg. 2013;75(4):635–641.
93.
VarpulaTValtaPNiemiRTakkunenOHynynenMPettilaVV. Airway pressure release ventilation as a primary ventilatory mode in acute respiratory distress syndrome. Acta Anaesthesiol Scand. 2004;48(6):722–731.
94.
MaxwellRAGreenJMWaldropJ, et al.A randomized prospective trial of airway pressure release ventilation and low tidal volume ventilation in adult trauma patients with acute respiratory failure. J Trauma. 2010;69(3):501–510; discussion 511.
95.
GonzalezMArroligaACFrutos-VivarF, et al.Airway pressure release ventilation versus assist-control ventilation: a comparative propensity score and international cohort study. Intensive Care Med. 2010;36(5):817–827.
96.
ZhouYJinXLvY, et al.Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome. 2017;43(11):1648–1659.
97.
MercatATitirigaMAnguelNRichardCTeboulJL. Inverse ratio ventilation (I/E = 2/1) in acute respiratory distress syndrome: a six-hour controlled study. Am J Respir Crit Care Med. 1997;155(5):1637–1642.
98.
LessardMRGuerotELorinoHLemaireFBrochardL. Effects of pressure-controlled with different I:E ratios versus volume-controlled ventilation on respiratory mechanics, gas exchange, and hemodynamics in patients with adult respiratory distress syndrome. Anesthesiology. 1994;80(5):983–991.
99.
ManceboJVallverduIBakE, et al.Volume-controlled ventilation and pressure-controlled inverse ratio ventilation: a comparison of their effects in ARDS patients. Monaldi Arch Chest Dis1994;49(3):201–207.
100.
HuangCCShihMJTsaiYHChangYCTsaoTCHsuKH. Effects of inverse ratio ventilation versus positive end-expiratory pressure on gas exchange and gastric intramucosal PCO(2) and pH under constant mean airway pressure in acute respiratory distress syndrome. Anesthesiology. 2001;95(5):1182–1188.
101.
SorokskyAEsquinasA. Goal-directed mechanical ventilation: are we aiming at the right goals? A proposal for an alternative approach aiming at optimal lung compliance, guided by esophageal pressure in acute respiratory failure. Crit Care Res Pract. 2012. doi:10.1155/2012/597932.
102.
ChiumelloDCressoniMColomboA, et al.The assessment of transpulmonary pressure in mechanically ventilated ARDS patients. Intensive Care Med. 2014;40(11):1670–1678.
103.
ChiumelloDGuerinC. Understanding the setting of PEEP from esophageal pressure in patients with ARDS. Intensive Care Med. 2015;41(8):1465–1467.
104.
TalmorDSargeTO’DonnellCR, et al.Esophageal and transpulmonary pressures in acute respiratory failure. Crit Care Med. 2006;34(5):1389–1394.
105.
TalmorDSargeTMalhotraA, et al.Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med. 2008;359(20):2095–2104.
106.
SorokskyAKheifetsJGirsh SolomonovichZTayemEGingy RonenBRozhavskyB. Managing hypercapnia in patients with severe ARDS and low respiratory system compliance: the role of esophageal pressure monitoring –a case–cohort study. Bio Med Res Int. 2015;2015:385042.
107.
ChiumelloDCressoniMCarlessoE, et al.Bedside selection of positive end-expiratory pressure in mild, moderate, and severe acute respiratory distress syndrome. Crit Care Med. 2014;42(2):252–264.
108.
BeitlerJRSargeTBanner-GoodspeedVM, et al.Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-FiO2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2019;321(9):846–857.
109.
FishENovackVBanner-GoodspeedVMSargeTLoringSTalmorD. The esophageal pressure-guided ventilation 2 (EPVent2) trial protocol: a multicentre, randomised clinical trial of mechanical ventilation guided by transpulmonary pressure. BMJ Open. 2014;4(9):e006356.
110.
GuerinCReignierJRichardJC, et al.Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159–2168.
111.
MartindaleRGMcClaveSAVanekVW, et al.Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine and american society for parenteral and enteral nutrition: executive summary. Crit Care Med. 2009;37(5):1757–1761.
112.
RiceTWWheelerAPThompsonBT, et al.Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA. 2012;307(8):795–803.
113.
NeedhamDMDinglasVDBienvenuOJ, et al.One year outcomes in patients with acute lung injury randomised to initial trophic or full enteral feeding: prospective follow-up of EDEN randomised trial. BMJ. 2013;346:f1532.
114.
NeedhamDMDinglasVDMorrisPE, et al.Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med. 2013;188(5):567–576.
115.
LekkaMELiokatisSNathanailCGalaniVNakosG. The impact of intravenous fat emulsion administration in acute lung injury. Am J Respir Crit Care Med. 2004;169(5):638–644.
116.
SuchnerUKatzDPFurstP, et al.Effects of intravenous fat emulsions on lung function in patients with acute respiratory distress syndrome or sepsis. Crit Care Med. 2001;29(8):1569–1574.
117.
HarveySEParrottFHarrisonDA, et al.Trial of the route of early nutritional support in critically ill adults. N Engl J Med. 2014;371(18):1673–1684.
118.
SingerPTheillaMFisherHGibsteinLGrozovskiECohenJ. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34(4):1033–1038.
119.
GadekJEDeMicheleSJKarlstadMD, et al.Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999;27(8):1409–1420.
120.
RiceTWWheelerAPThompsonBT, et al.Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011;306(14):1574–1581.
121.
StapletonRDMartinTRWeissNS, et al.A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med. 2011;39(7):1655–1662.
122.
DevlinJWSkrobikYGélinasC, et al.Clinical Practice Guidelines for the Prevention and Management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
123.
Hansen-FlaschenJ.Improving patient tolerance of mechanical ventilation. Challenges ahead. Crit Care Clin. 1994;10(4):659–671.
124.
SwinamerDLPhangPTJonesRLGraceMKingEG. Effect of routine administration of analgesia on energy expenditure in critically ill patients. Chest. 1988;93(1):4–10.
125.
ShahFAGirardTDYendeS. Limiting sedation for patients with acute respiratory distress syndrome – time to wake up. Curr Opin Crit Care. 2017;23(1):45–51.
126.
KressJPPohlmanASO’ConnorMFHallJB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471–1477.
127.
TakalaJ. Of delirium and sedation. Am J Respir Crit Care Med. 2014;189(6):622–624.
128.
BarrJFraserGLPuntilloK, et al.Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
129.
WilhelmWKreuerS. The place for short-acting opioids: special emphasis on remifentanil. Crit Care. 2008;12(suppl 3):S5.
130.
ShehabiYBellomoRReadeMC, et al.Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med. 2012;186(8):724–731.
131.
TanakaLMAzevedoLCParkM, et al.Early sedation and clinical outcomes of mechanically ventilated patients: a prospective multicenter cohort study. Crit Care. 2014;18(4):R156.
132.
TreggiariMMRomandJAYanezND, et al.Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med. 2009;37(9):2527–2534.
133.
JacksonJCGirardTDGordonSM, et al.Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med. 2010;182(2):183–191.
134.
GirardTDJacksonJCPandharipandePP, et al.Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513–1520.
135.
BrookADAhrensTSSchaiffR, et al.Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27(12):2609–2615.
136.
KahnJMAnderssonLKarirVPolissarNLNeffMJRubenfeldGD. Low tidal volume ventilation does not increase sedation use in patients with acute lung injury. Crit Care Med. 2005;33(4):766–771.
137.
WolthuisEKVeeloDPChoiG, et al.Mechanical ventilation with lower tidal volumes does not influence the prescription of opioids or sedatives. Crit Care. 2007;11(4):R77.
138.
Serpa NetoASimonisFDBarbasCS, et al.Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis. Intensive Care Med. 2014;40(7):950–957.
139.
ArroligaACThompsonBTAncukiewiczM, et al.Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med. 2008;36(4):1083–1088.
140.
MehtaSCookDJSkrobikY, et al.A ventilator strategy combining low tidal volume ventilation, recruitment maneuvers, and high positive end-expiratory pressure does not increase sedative, opioid, or neuromuscular blocker use in adults with acute respiratory distress syndrome and may improve patient comfort. Ann Intensive Care. 2014;4:33.
141.
ChengIWEisnerMDThompsonBTWareLBMatthayMA. Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injury. Crit Care Med. 2005;33(1):63–70; discussion 239-240.
142.
PandharipandePShintaniAPetersonJ, et al.Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104(1):21–26.
143.
LonardoNWMoneMCNirulaR, et al.Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients. Am J Respir Crit Care Med. 2014;189(11):1383–1394.
144.
RikerRRShehabiYBokeschPM, et al.Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5):489–499.
145.
JakobSMRuokonenEGroundsRM, et al.Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151–1160.
146.
PandharipandePPPunBTHerrDL, et al.Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644–2653.
147.
BarrJFraserGLPuntilloK, et al.Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit: executive summary. Am J Health-Syst Pharm. 2013;70(1):53–58.
148.
DevabhakthuniSArmahizerMJDastaJFKane-GillSL. Analgosedation: a paradigm shift in intensive care unit sedation practice. Ann Pharmacother. 2012;46(4):530–540.
149.
StromTMartinussenTToftP. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet. 2010;375(9713):475–480.
150.
GainnierMRochAForelJM, et al.Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2004;32(1):113–119.
151.
ForelJMRochAMarinV, et al.Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2006;34(11):2749–2757.
152.
PapazianLForelJMGacouinA, et al.Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107–1116.
153.
AlhazzaniWAlshahraniMJaeschkeR, et al.Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2013;17(2):R43.
154.
MossMHuangDTBrowerRG, et al.Early neuromuscular blockade in the acute respiratory distress syndrome. The New England Journal of Medicine. 2019;380(21):1997–2008.
155.
WatlingSMDastaJF. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature. Crit Care Med. 1994;22(5):884–893.
156.
WestphalKStrouhalUByhahnCHommelKBehneM. Inhalation of nitric oxide in severe lung failure. Anaesthesiol Reanim. 1998;23(6):144–148.
DellingerRPZimmermanJLTaylorRW, et al.Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998;26(1):15–23.
159.
MichaelJRBartonRGSaffleJR, et al.Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998;157(5 pt 1):1372–1380.
160.
TaylorRWZimmermanJLDellingerRP, et al.Inhaled nitric oxide in ASG. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA. 2004;291(13):1603–1609.
161.
DupontHLe CorreFFierobeLChevalCMoinePTimsitJF. Efficiency of inhaled nitric oxide as rescue therapy during severe ARDS: survival and factors associated with the first response. J Crit Care. 1999;14(3):107–113.
162.
AngusDCClermontGLinde-ZwirbleWT, et al.Healthcare costs and long-term outcomes after acute respiratory distress syndrome: a phase III trial of inhaled nitric oxide. Crit Care Med. 2006;34(12):2883–2890.
163.
DellingerRPTrzeciakSWCrinerGJ, et al.Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome. Crit Care. 2012;16(2):R36.
164.
AdhikariNKDellingerRPLundinS, et al.Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med. 2014;42(2):404–412.
165.
DunkleyKALouzonPRLeeJVuS. Efficacy, safety, and medication errors associated with the use of inhaled epoprostenol for adults with acute respiratory distress syndrome: a pilot study. Ann Pharmacother. 2013;47(6):790–796.
166.
SawhenyEEllisALKinasewitzGT. Iloprost improves gas exchange in patients with pulmonary hypertension and ARDS. Chest. 2013;144(1):55–62.
167.
DahlemPvan AalderenWMde NeefMDijkgraafMGBosAP. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury. Crit Care Med. 2004;32(4):1055–1060.
168.
WalmrathDSchneiderTSchermulyROlschewskiHGrimmingerFSeegerW. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;153(3):991–996.
169.
TorbicHSzumitaPMAngerKENuccioPLaGambinaSWeinhouseG. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care. 2013;28(5):844–848.
170.
CornetADHofstraJJSwartELGirbesARJuffermansNP. Sildenafil attenuates pulmonary arterial pressure but does not improve oxygenation during ARDS. Intensive Care Med. 2010;36(5):758–764.
171.
WeigeltJANorcrossJFBormanKRSnyderWH3rd. Early steroid therapy for respiratory failure. Arch Surg. 1985;120(5):536–540.
172.
BoneRCFisherCJJrClemmerTPSlotmanGJMetzCA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987;92(6):1032–1036.
173.
SteinbergKPHudsonLDGoodmanRBet al; Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671–1684.
174.
DealENHollandsJMSchrammGEMicekST. Role of corticosteroids in the management of acute respiratory distress syndrome. Clin Ther. 2008;30(5):787–799.
175.
PeterJVJohnPGrahamPLMoranJLGeorgeIABerstenA. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ. 2008;336(7651):1006–1009.
176.
MeduriGUGoldenEFreireAX, et al.Methylprednisolone infusion in early severe ARDS results of a randomized controlled trial. 2007. Chest. 2009;136(5 suppl):e30.
177.
TangBMCraigJCEslickGDSeppeltIMcLeanAS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med. 2009;37(5):1594–1603.
178.
MeduriGUBridgesLShihMCMarikPESiemieniukRAKocakM. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42(5):829–840.
179.
Ortiz-DiazELiGKorD. Preadmission use of inhaled corticosteroids is associated with a reduced risk of direct acute lung injury/acute respiratory distress syndrome. Chest. 2011;140:912A.
180.
WegJGBalkRATharrattRS, et al.Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA. 1994;272(18):1433–1438.
181.
AnzuetoABaughmanRPGuntupalliKK, et al.Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf acute respiratory distress syndrome sepsis study group. N Engl J Med. 1996;334(22):1417–1421.
182.
SpraggRGLewisJFWalmrathHD, et al.Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med. 2004;351(9):884–892.
183.
DavidsonWJDorscheidDSpraggRSchulzerMMakEAyasNT. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care. 2006;10(2):R41.
184.
KeseciogluJBealeRStewartTE, et al.Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2009;180(10):989–994.
185.
WillsonDFThomasNJMarkovitzBP, et al.Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005;293(4):470–476.
186.
TautFJRippinGSchenkP, et al.A Search for subgroups of patients with ARDS who may benefit from surfactant replacement therapy: a pooled analysis of five studies with recombinant surfactant protein-C surfactant (Venticute). Chest. 2008;134(4):724–732.
187.
SpraggRGTautFJLewisJF, et al.Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury. Am J Respir Crit Care Med. 2011;183(8):1055–1061.
188.
ParkSYKimHJYooKH, et al.The efficacy and safety of prone positioning in adults patients with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. J Thorac Dis. 2015;7(3):356–367.
189.
Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med. 2002;30(1):1–6.
190.
JepsenSHerlevsenPKnudsenPBudMIKlausenNO. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med. 1992;20(7):918–923.
191.
BernardGRWheelerAPAronsMM, et al.A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest. 1997;112(1):164–172.
192.
SuterPMDomenighettiGSchallerMDLaverriereMCRitzRPerretC. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest. 1994;105(1):190–194.
193.
DomenighettiGSuterPMSchallerMDRitzRPerretC. Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care. 1997;12(4):177–182.
194.
MoradiMMojtahedzadehMMandegariA, et al.The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir Med. 2009;103(3):434–441.
195.
WalkeyAJWienerRS. Macrolide antibiotics and survival in patients with acute lung injury. Chest. 2012;141(5):1153–1159.
196.
YuMTomasaG. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med. 1993;21(11):1635–1642.
Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network. JAMA. 2000;283(15):1995–2002.
199.
Ortiz-DiazEFesticEGajicOLevittJE. Emerging pharmacological therapies for prevention and early treatment of acute lung injury. Semin Respir Crit Care Med. 2013;34(4):448–458.
200.
BoyleAJMac SweeneyRMcAuleyDF. Pharmacological treatments in ARDS: a state-of-the-art update. BMC Med. 2013;11:166.
201.
Trillo-AlvarezCAKashyapRKojicicMLiGThakurS. Chronic use of angiotensin pathway inhibitors is associated with a decreased risk of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2009;179(1):A4638.
202.
WatkinsTRLemos-FilhoLBDabbaghOChangSYParkPK. Use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers and clinical outcomes among patients at-risk for acute lung injury. In American Thoracic Society International Conference, 2011, Denver, CO.
203.
WalterJWareLBMatthayMA. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. Lancet Respir Med. 2014;2(12):1016–1026.
204.
RojasMXuJWoodsCR, et al.Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 2005;33(2):145–152.
205.
SerikovVBMikhaylovVMKrasnodembskayADMatthayMA. Bone marrow-derived cells participate in stromal remodeling of the lung following acute bacterial pneumonia in mice. Lung. 2008;186(3):179–190.
206.
GuptaNSuXPopovBLeeJWSerikovVMatthayMA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007;179(3):1855–1863.
207.
McIntyreLAMoherDFergussonDA, et al.Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review. PloS one. 2016;11(1):e0147170.
208.
LeeJWKrasnodembskayaAMcKennaDHSongYAbbottJMatthayMA. Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med. 2013;187(7):751–760.
209.
ZhengGHuangLTongH, et al.Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res. 2014;15:39.
210.
WilsonJGLiuKDZhuoH, et al.Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015;3(1):24–32.
